首页> 美国卫生研究院文献>Journal of Neurotrauma >Repetitive Transcranial Magnetic Stimulation with Resting-State Network Targeting for Treatment-Resistant Depression in Traumatic Brain Injury: A Randomized Controlled Double-Blinded Pilot Study
【2h】

Repetitive Transcranial Magnetic Stimulation with Resting-State Network Targeting for Treatment-Resistant Depression in Traumatic Brain Injury: A Randomized Controlled Double-Blinded Pilot Study

机译:以静息状态网络为目标的重复性经颅磁刺激治疗创伤性脑损伤的抗抑郁药:一项随机对照双盲试验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Repetitive transcranial magnetic stimulation (rTMS) has demonstrated antidepressant efficacy but has limited evidence in depression associated with traumatic brain injury (TBI). Here, we investigate the use of rTMS targeted with individualized resting-state network mapping (RSNM) of dorsal attention network (DAN) and default mode network (DMN) in subjects with treatment-resistant depression associated with concussive or moderate TBI. The planned sample size was 50 with first interim analysis planned at 20, but only 15 were enrolled before the study was terminated for logistical reasons. Subjects were randomized to 20 sessions of bilateral rTMS (4000 left-sided excitatory pulses, 1000 right-sided inhibitory pulses) or sham. Treatment was targeted to the dorsolateral prefrontal cluster with maximal difference between DAN and DMN correlations based on resting-state functional magnetic resonance imaging with individualized RSNM. Mean improvement in the primary outcome, Montgomery-Asberg Depression Rating Scale (MADRS), was 56% ± 14% (  = 9) with active treatment and 27% ± 25% (  = 5) with sham (Cohen's  = 1.43). One subject randomized to sham withdrew before starting treatment. There were no seizures or other significant adverse events. MADRS improvement was inversely correlated with functional connectivity between the right-sided stimulation site and the subgenual anterior cingulate cortex (sgACC;  = -0.68, 95% confidence interval 0.03-0.925). Active treatment led to increased sgACC-DMN connectivity (  = 1.55) and increased sgACC anti-correlation with the left- and right-sided stimulation sites (  = -1.26 and -0.69, respectively). This pilot study provides evidence that RSNM-targeted rTMS is feasible in TBI patients with depression. Given the dearth of existing evidence-based treatments for depression in this patient population, these preliminarily encouraging results indicate that larger controlled trials are warranted.
机译:重复经颅磁刺激(rTMS)已显示出抗抑郁功效,但在与颅脑外伤(TBI)相关的抑郁症中证据有限。在这里,我们研究了在患有脑震荡或中度TBI伴有抗药性抑郁症的受试者中使用rTMS靶向背侧注意力网络(DAN)和默认模式网络(DMN)的个性化静止状态网络映射(RSNM)。计划的样本量为50,首次中期分析计划为20,但是由于后勤原因,在终止研究之前仅招募了15名。将受试者随机分为20个双侧rTMS(4000个左侧兴奋性脉冲,1000个右侧抑制性脉冲)或假手术。基于静止状态功能磁共振成像和个性化RSNM,治疗针对DAN和DMN相关性之间最大差异的背外侧前额簇。蒙哥马利-阿斯伯格抑郁量表(MADRS)的主要疗效平均改善为积极治疗为56%±14%(= 9),假手术为27%±25%(= 5)(Cohen's = 1.43)。随机接受假手术的一名受试者在开始治疗前退出。没有癫痫发作或其他重大不良事件。 MADRS的改善与右侧刺激部位和膝下扣带回皮层之间的功能连通性呈负相关(sgACC; = -0.68,95%置信区间0.03-0.925)。积极治疗导致sgACC-DMN连接性增加((= 1.55),并增加了sgACC与左侧和右侧刺激位点的抗相关性(分别为= -1.26和-0.69)。这项初步研究提供了证据,以RSNM为靶点的rTMS在TBI抑郁症患者中是可行的。鉴于该患者人群中现有的基于证据的抑郁症治疗药物匮乏,这些初步令人鼓舞的结果表明,需要进行更大的对照试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号